glp-1 drugs and crohn's disease Use in Disease: Safety & IBD Considerations – PlexusDx GLP-1 Agonists and Crohn's Disease:

Methods: Databases including PubMed, Scopus, and Embase, Web of Science, and Google Scholar were searched up to June 2023

Whey protein supplementation was used as monotherapy in few of the patients who showed improvement

Who should avoid Sermorelin

R., Gallo, M., Apata, T., Van Dis, J

Although the ELIXA studythe only CVD outcome trial of GLP-1 RAs published to datereported a neutral cardiovascular effect of lixisenatide, the potential cardiovascular benefits of GLP-1 RAs should not be overlooked, because high-risk subjects with established CVD were recruited in this study to delineate its cardiovascular safety within a short-term period